hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair

• Päätekijät: Wei Wang (Tekijä), Yahao Wang (Tekijä), Jingwei Chi (Tekijä), Xiaojun Tan (Tekijä), Jianxia Hu (Tekijä), Xiaolong Ma (Tekijä), Xiaofang Sun (Tekijä), Kui Che (Tekijä), Wenshan Lv (Tekijä), Yangang Wang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2022-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Exenatide is a stable analogue of glucagon-like peptide 1 that can reduce postprandial hyperglycemia and has been utilized as adjunctive therapy for type 1 diabetes mellitus (T1DM). The human umbilical cord is a rich source of MSCs, and human umbilical cord mesenchymal stem cells...